Technical Support: Archives

2012 to 2013

Institutional Strengthening: South African Vaccination and Immunisation Centre (SAVIC)

Pretoria-South Africa 1 January, 2012 to 31 December, 2013

The recommendation of the Oversight Committee to establish focal offices has been taken up and discussions with the South African Vaccination and Immunisation Centre (SAVIC), which is hosted at the University of Limpopo, Medunsa Campus, South Africa, were initiated during 2011 on how to formalise the long-standing collaboration between SAVIC and NESI. The Agreement was finalised at the end of 2011 and came into action as from 1 January 2012.

SAVIC and NESI share a common goal of improving the quality and sustainability of immunisation programmes, through Peducation and training. SAVIC and NESI have a long working relationship spanning over 10 years. SAVIC was established at Medunsa Campus of University of Limpopo in 2003. It is a network of partners in the field of vaccination and immunisation. SAVIC is a Public Private Academic alliance between the South African Department of Health, Vaccine Industry, Academic institutions and other stakeholders. SAVIC activities are undertaken in close collaboration with the South African National Department of Health, NESI/UA, WHO and other partners.

The strategic operational areas of SAVIC include Education and Training, Operational Research and Technical Support and Advocacy. 

                                         

 

 

 

                                                                      

 

 

 

                                                                 

 

 

                              

 

 

 


2011

Meeting on review and evaluation of the second Vaccination Week and planning of the third Vaccination Week

Dubai, UAE 20 October, 2011

A meeting on review and evaluation of the second Vaccination Week and planning of the third Vaccination Week was organised by WHO/EMRO in Dubai, UAE, on 20 October 2011.

The meeting was attended by MoH representatives from 19 countries (Afghanistan, Bahrain, Djibouti, Egypt, Islamic Republic of Iran, Iraq, Jordan, Kuwait, Oman, Pakistan, Palestine, Qatar, Saudi Arabia, Somalia, Sudan, Republic of South Sudan, Syrian Arab Republic, Tunisia and United Arab Emirates), as well as RTAG and NITAG members, WHO, UNICEF and NESI.

The objectives of the meeting included:

  • To share experiences and best practices of the region in the second regional vaccination week in 2011
  • To agree on common regional or sub-regional theme and slogan for the third regional vaccination week in 2012

Participants at the meeting shared their best practices of the second Vaccination Week. It is important that the events are nationally focused but have regional relevance. A regional theme should be developed to encourage focused Vaccination Week efforts. Early coordination among countries is crucial for joint launching ceremonies and activities at border areas. Strong involvement from partners (NGOs, media, leaders, academic institutions, etc.) is essential to the success of the Vaccination Week. It was suggested that the next Vaccination Week should explore possibilities to reach the most marginalised and hard-to-reach populations.

The overall objectives and strategies for the third Vaccination Week will be similar to those of the second Vaccination Week. Specific topics were discussed for the 2012 Vaccination Week, taking into account the lessons learnt and best practices of 2011: target audiences; potential activities to be organised; cross border activities; media products and activities; evaluation; key messages; visual representation; regional launching ceremony. 

Second Vaccination Week

Eastern Mediterranean Region 21 April, 2011 to 30 April, 2011

In 2005, WHO/EMRO adopted the regional vision that "No child should die from vaccine-preventable diseases". Since then, the Eastern Mediterranean Region has made remarkable progress in reducing morbidity and mortality due to vaccine-preventable diseases.

Vaccination coverage with three doses of DTP3 has increased from 18% in 1980 to 87% in 2009. Twenty countries maintained their polio-free status. The 90% measles mortality reduction target was reached three years ahead of schedule. An increasing number of countries are introducing new and under-utilised vaccines.

However, despite this substantial progress, the Region still faces many challenges: in 2009, approximately 1.9 million children did not receive DTP3 by their first birthday; Afghanistan and Pakistan are still polio-endemic countries; maternal and neonatal tetanus are still not eliminated; and the success of measles mortality reduction needs to be sustained.

To address both the opportunities and challenges, WHO/EMRO coordinated the second Vaccination Week in the Eastern and Mediterranean Region during the week of 24-30 April 2011. The Vaccination Week in the Eastern Mediterranean Region is an annual region-wide initiative promoting the value of immunisation through advocacy, education and communication activities. The theme for the 2011 Vaccination Week was "partnership for immunisation".

The objectives of the Immunisation Week included:

(1) Increasing stakeholder awareness of the value of immunisation;

(2) Promoting and maintaining immunisation as a priority for policy- and decision-making;

(3) Advocating for and mobilising human and financial resources; and

(4) Improving access to immunisation for high-risk populations and hard-to-reach areas in the Region.

Strategies used included: targeted advocacy and education; communication and media activities; and expansion of immunisation services.

The Regional Launch of the Vaccination Week took place in Cairo, Egypt, on 21 April 2011. Dr. Hussein A. Gezairy, WHO Regional Director for the Eastern Mediterranean, addressed senior officials from the ministries, local organisations and the media. The ceremony was followed by a panel discussion with members of academia, media, governmental and non-governmental organisations. Twenty countries in the Eastern and Mediterranean Region participated in the second Vaccination Week. Almost all countries in the Region organised a national launching ceremony. All participating countries implemented advocacy, education and communication activities. Implemented activities included: mass media campaigns; social mobilisation: awareness events, public meetings, activities in schools; training of health professionals, and medical and nursing students; meetings: round-table, seminars; exhibitions and awards. Countries set their own objectives based on national priorities and epidemiological situation.

The second Vaccination Week in the Eastern Mediterranean Region was a successful event in increasing awareness on the importance and benefits of immunisation in the Region. 

Launch of Pneumococcal Conjugate Vaccine

Nairobi, Kenya 14 February, 2011

Kenya was the first African country that introduced the new pneumococcal conjugate vaccine, PCV10, in their national immunisation programme. The vaccine protects children against pneumococcal diseases like pneumonia, meningitis and bacteraemia. The roll out of the vaccine in developing countries is possible through a novel financing mechanism, the Advanced Market Commitment.

NESI was invited by the Ministry of Public Health and Sanitation (MoPHS) of Kenya to attend the official launch of the pneumococcal conjugate vaccine on 14 February 2011 in Nairobi, Kenya. NESI received enormous visibility being acknowledged on all advocacy and training materials (Fig. 8). It clearly shows that NESI is a full partner in the introduction process of this new pneumococcal conjugate vaccine in the EPI programme in Kenya. More specifically, NESI provided core technical input and finishing touches on the development of the training materials on pneumococcal conjugate vaccine, particularly for the training DVD.

The Official Launch was moderated by the Permanent Secretary, Ministry of Public Health and Sanitation, Mr. Mark Bor. The launch was attended by vairous official authorities.

 Banner launch Pneumococcal Vaccine

2010

Workshop: Surveillance Of Vaccine Preventable Diseases And Monitoring And Evaluation Of National Immunization Programme

Sharm El Sheikh, Egypt 4 December, 2010 to 6 December, 2010

The WHO Regional Office for the Eastern Mediterranean organised an Inter-Country Workshop on Surveillance of Vaccine Preventable Diseases and Monitoring and Evaluation of National Immunization programme from 4-6 December 2010 in Sharm El Sheikh, Egypt.

The workshop was attended by National EPI Managers, measles surveillance officers and measles laboratory surveillance officers from EMR member states, Representatives from UNICEF Regional and Country Offices, CDC Atlanta, the Network for Education and Support in Immunisation (NESI). In addition, WHO staff from the Regional and Country Offices and WHO/HQ participated in the meeting.

The objectives of the workshop were:

(1) to review Vaccine Preventable Diseases surveillance, Regional Surveillance Networks and EPI monitoring and evaluation in countries of the EMR;

(2) to discuss the regional reporting system with the national focal points;

(3) to conduct a briefing on data management, data analysis and interpretation; and

(4) to brief the participants on approaches and tools for surveillance, monitoring and evaluation.

During the workshop, the participants were briefed on vaccine preventable diseases surveillance, which included  the Global Framework on Immunization, Monitoring and Surveillance; the current situation on VPD’s surveillance in EMR; Guidelines on vaccine impact assessment; Disease burden estimates; Hepatitis B surveillance and sero-surveys; Hepatitis B monitoring and evaluation tools; Monitoring and evaluation of EPI, which included briefing on Data Quality Self assessment (DQS) and cluster coverage surveys, using district level data; updated WHO/UNICEF Joint Reporting Form 2011; WHO/UNICEF estimate of vaccination coverage; and Post Introduction Evaluations.

Inter-Country Meeting Of National Managers Of The Expanded Programme On Immunization And 2Nd Meeting Of The Chairspersons Of The National Immunization Technical Advisory Group In The Emr Countries

Cairo, Egypt 4 July, 2010 to 6 July, 2010

WHO/EMRO, in collaboration with UNICEF/MENARO, organised the meeting for the national managers of the Expanded Programme on Immunization (EPI) in the Eastern Mediterranean Region (EMR) Countries in Cairo, Egypt on 4, 5 and 6 July 2010 and a back-to-back meeting for the chairpersons of the National Immunization Technical Advisory Group on 7 July 2010.

The purpose of this four days meeting was to brief the national EPI managers and NITAG chairpersons on main VPI (vaccine preventable infections) areas of work, priorities, targets (mainly control, elimination and eradication of VPI), strategies and challenges, as well as their expected contribution.

Objectives of the meeting were:

(1) To review national and regional progress in EPI: achievements, constraints and way forward;

(2) To discuss recent advances in new vaccines and technologies: progress and constraints and the challenges facing their use;

(3) To discuss progress towards polio eradication: achievements, constraints and way forward;

(4) To discuss progress towards measles elimination: achievements, constraints and way forward;

(5) To discuss progress towards Hepatitis B control: achievements, constraints and way forward; and

(6) To brief NITAG chairpersons on progress and constraints facing EPI and the expected role of NITAG supporting EPI.

The meeting was organized around six sessions: Global and regional briefings/Protecting more people: reaching the unreached/ Achieving the regional targets/Introducing new vaccines and technologies/Strengthen EPI logistics system/Initiative for strengthening EPI.

Vaccination Week in the Eastern Mediterranean Region

Mediterranean Region 24 April, 2010 to 30 April, 2010

The WHO Eastern Mediterranean Region has made remarkable success in reducing morbidity and mortality due to vaccine-preventable diseases. Vaccination coverage with three doses of DTP3 has increased from 18% in 1980 to 87% in 2009. The 90% measles mortality reduction target was reached three years ahead of schedule and polio-free status was maintained in 20 countries.

Despite this considerable progress, the Region continues to face major challenges: every day, more than 5,000 infants do not complete their routine immunisation schedule; an estimated 1.9 million children did not receive DTP3 vaccine in 2009; Afghanistan and Pakistan are still polio-endemic countries; maternal and neonatal tetanus are still in circulation; and the success of measles mortality reduction needs to be sustained.

To address both the opportunities and challenges, WHO/EMRO in partnership with UNICEF and other stakeholders, launched the first Vaccination Week in the Eastern and Mediterranean Region during the week of 24-30 April 2010. This was at the same time as the European Immunisation week and the Vaccination Week in the Americas. The Vaccination Week in the Eastern Mediterranean Region will be an annual region-wide initiative promoting immunisation through advocacy, education and communication activities.

All countries in the Eastern and Mediterranean Region participated in the first Vaccination Week.

The objectives of the vaccination week include:

(1) Increasing stakeholder awareness of the value of immunisation;

(2) promoting and maintaining immunisation as a priority for policy- and decision-making;

(3) advocating for and mobilising human and financial resources; and

(4) improving access to immunisation for high-risk populations and hard-to-reach areas in the Region. Strategies used included: targeted advocacy and education; communication and media activities; and expansion of immunisation services.

Almost all countries in the Region organised national launching events to celebrate the Vaccination Week. Countries developed their own national objectives based on national goals and epidemiological evidence and decided which key activities to implement.

Activities conducted during the Vaccination Week included:

  • Large-scale vaccination campaigns;
  • Aligning Child Health Days to deliver an integrated package of life-saving health interventions;
  • Mass media campaigns;
  • Social mobilisation: awareness events, public meetings, activities in schools;
  • Training of health professionals, and medical and nursing students;
  • Meetings: round-table, seminars.

The first Vaccination Week in the Eastern Mediterranean Region was a successful event in increasing awareness on the importance and benefits of immunisation in the Region.

Workshop: Supporting Countries in Establishing National Immunisation Technical Advisory Group

Tunisia 16 February, 2010 to 18 February, 2010

WHO/EMRO organised a joint mission with Agence de Médicine Préventive (AMP) and NESI to Tunisia from 16 to 18 February 2010 to explore the feasibility to establish a NITAG (National Immunisation Technical Advisory Group) according to the guidance given by WHO and the SIVAC Initiative (Supporting Independent Immunisation and Vaccine Advisory Committees). Tunisia is one of the 2 pilot countries in the Region for this Initiative.

Tunisia as many other countries already had a national advisory group of experts on immunisation, and discussions with health authorities focused to see if the country could comply with all the formal criteria, among others of independency, of a NITAG as outlined by the SIVAC Initiative. In particular the relationships and interactions between NITAG, NRA (National Regulatory Authority) and national EPI programme have to be looked into. After consultations with many immunisation experts from universities, schools of public health and health sciences, clinicians in the private sector, nursing and medical professional bodies, the EPI programme and the Ministry of Health, a debriefing was held with the Minister of Health, who agreed in principle to go forward and re-orient the existing advisory body into a formal NITAG.

Last updated: 5 July, 2017